These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 18273760)

  • 41. Hereditary non-polyposis colorectal cancer or Lynch syndrome: the gynaecological perspective.
    Manchanda R; Menon U; Michaelson-Cohen R; Beller U; Jacobs I
    Curr Opin Obstet Gynecol; 2009 Feb; 21(1):31-8. PubMed ID: 19125001
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Colonoscopy surveillance in asymptomatic subjects with increased risk for colorectal cancer: clinical evaluation and cost analysis of an Italian experience.
    Matarese VG; Feo CV; Pezzoli A; Trevisani L; Brancaleoni M; Gullini S
    Eur J Cancer Prev; 2007 Aug; 16(4):292-7. PubMed ID: 17554201
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cost-effectiveness analysis between primary and secondary preventive strategies for gastric cancer.
    Lee YC; Lin JT; Wu HM; Liu TY; Yen MF; Chiu HM; Wang HP; Wu MS; Hsiu-Hsi Chen T
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):875-85. PubMed ID: 17507609
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model.
    Wordsworth S; Leal J; Blair E; Legood R; Thomson K; Seller A; Taylor J; Watkins H
    Eur Heart J; 2010 Apr; 31(8):926-35. PubMed ID: 20299350
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening.
    Wilschut JA; Hol L; Dekker E; Jansen JB; Van Leerdam ME; Lansdorp-Vogelaar I; Kuipers EJ; Habbema JD; Van Ballegooijen M
    Gastroenterology; 2011 Nov; 141(5):1648-55.e1. PubMed ID: 21784045
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cost-effectiveness of psoriasis therapy with etanercept in Germany.
    Heinen-Kammerer T; Daniel D; Stratmann L; Rychlik R; Boehncke WH
    J Dtsch Dermatol Ges; 2007 Sep; 5(9):762-8. PubMed ID: 17760896
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cost-effectiveness analysis of immunochemical occult blood screening for colorectal cancer among three fecal sampling methods.
    Yamamoto M; Nakama H
    Hepatogastroenterology; 2000; 47(32):396-9. PubMed ID: 10791199
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cost-effectiveness analysis of colorectal cancer screening strategies in Singapore: a dynamic decision analytic approach.
    Wong SS; Leong AP; Leong TY
    Stud Health Technol Inform; 2004; 107(Pt 1):104-10. PubMed ID: 15360784
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ["Cost-effectiveness" of cervical screening].
    Kostova P
    Akush Ginekol (Sofiia); 2007; 46(6):32-4. PubMed ID: 17974169
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cost-effectiveness of screening for hepatopulmonary syndrome in liver transplant candidates.
    Roberts DN; Arguedas MR; Fallon MB
    Liver Transpl; 2007 Feb; 13(2):206-14. PubMed ID: 17205561
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cost-effectiveness of 4 neonatal screening strategies for cystic fibrosis.
    van den Akker-van Marle ME; Dankert HM; Verkerk PH; Dankert-Roelse JE
    Pediatrics; 2006 Sep; 118(3):896-905. PubMed ID: 16950979
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Colorectal cancer screening: health impact and cost effectiveness.
    Maciosek MV; Solberg LI; Coffield AB; Edwards NM; Goodman MJ
    Am J Prev Med; 2006 Jul; 31(1):80-9. PubMed ID: 16777546
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Finding future high-cost cases: comparing prior cost versus diagnosis-based methods.
    Ash AS; Zhao Y; Ellis RP; Schlein Kramer M
    Health Serv Res; 2001 Dec; 36(6 Pt 2):194-206. PubMed ID: 16148969
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cost-effectiveness of neonatal ECG screening for the long QT syndrome.
    Quaglini S; Rognoni C; Spazzolini C; Priori SG; Mannarino S; Schwartz PJ
    Eur Heart J; 2006 Aug; 27(15):1824-32. PubMed ID: 16840497
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cost-effectiveness analysis of endometrial cancer prevention strategies for obese women.
    Kwon JS; Lu KH
    Obstet Gynecol; 2008 Jul; 112(1):56-63. PubMed ID: 18591308
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost-effectiveness of early one-year colonoscopy surveillance after polypectomy.
    Hassan C; Pickhardt PJ; Di Giulio E; Kim DH; Zullo A; Morini S
    Dis Colon Rectum; 2009 May; 52(5):964-71; discussion 971. PubMed ID: 19502863
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hospital health care resource utilization and costs of colorectal cancer during the first 3-year period following diagnosis in Switzerland.
    Delcò F; Egger R; Bauerfeind P; Beglinger C
    Aliment Pharmacol Ther; 2005 Mar; 21(5):615-22. PubMed ID: 15740546
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cost-effectiveness of alternative strategies for tuberculosis screening before kindergarten entry.
    Flaherman VJ; Porco TC; Marseille E; Royce SE
    Pediatrics; 2007 Jul; 120(1):90-9. PubMed ID: 17606566
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Economic evaluation of orthoptic screening: results of a field study in 121 German kindergartens.
    König HH; Barry JC; Leidl R; Zrenner E
    Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3209-15. PubMed ID: 12356826
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Evaluation of outpatient management in HNPCC].
    Bach K; Hüppe D; Schmiegel W; Epplen JT; Kunstmann E
    Z Gastroenterol; 2005 Jul; 43(7):647-51. PubMed ID: 16001346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.